It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Acute myocardial infarction is primarily due to coronary atherosclerotic plaque rupture and subsequent thrombus formation. Platelets play a key role in the genesis and progression of both atherosclerosis and thrombosis. Since platelets are anuclear cells that inherit their mRNA from megakaryocyte precursors and maintain it unchanged during their life span, gene expression profiling at the time of an acute myocardial infarction provides information concerning the platelet gene expression preceding the coronary event. In ST-segment elevation myocardial infarction (STEMI), a gene-by-gene analysis of the platelet gene expression identified five differentially expressed genes: FKBP5, S100P, SAMSN1, CLEC4E and S100A12. The logistic regression model used to combine the gene expression in a STEMI vs healthy donors score showed an AUC of 0.95. The same five differentially expressed genes were externally validated using platelet gene expression data from patients with coronary atherosclerosis but without thrombosis. Platelet gene expression profile highlights five genes able to identify STEMI patients and to discriminate them in the background of atherosclerosis. Consequently, early signals of an imminent acute myocardial infarction are likely to be found by platelet gene expression profiling before the infarction occurs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Department of Medicine and Surgery, University of Parma, Parma, Italy
2 Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy; Division of Research and Innovation, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
3 Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
4 Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy
5 Division of Research and Innovation, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy; Department of Statistics, Computer science, Applications, Univeristà di Firenze, Florence, Italy
6 Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA
7 School of Pharmacy and Biomedical Sciences, Faculty of Health Science, Curtin University, Perth, WA, Australia
8 Sidney Kimmel Cancer center, Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA; Department of Molecula Medicine, Sapienza University, Rome, Italy
9 Sidney Kimmel Cancer center, Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA
10 Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Utah, Salt Lake City, UT, USA
11 Department of Biomedical Sciences, Humanitas University, Milan, Italy
12 Center for Biostatistics, Institute of Population Health, University of Manchester, Manchester, UK